Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bonnet

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|June 7, 2022
Design and biological evaluation of substituted 5,7-dihydro-6<i>H</i>-indolo[2,3-<i>c</i>]quinolin-6-one as novel selective Haspin inhibitorsSreenivas Avula, Xudan Peng, Xingfen Lang, et al.
Virologie (Montrouge, France)|November 3, 2025
[Prozac 2.0 : from antidepressant to antiviral]Marine O Faucher, Safeh Khemiri, Carole Yaacoub, et al.
Journal of Medicinal Chemistry|January 23, 2015
Structural investigation of B-Raf paradox breaker and inducer inhibitorsRohit Arora, Michela Di Michele, Elisabeth Stes, et al.
Journal of Medicinal Chemistry|July 8, 2016
Correction to Structural Investigation of B-Raf Paradox Breaker and Inducer InhibitorsRohit Arora, Michela Di Michele, Elisabeth Stes, et al.
European Journal of Medicinal Chemistry|May 23, 2026
Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationshipsStéphane Bourg, Matthieu Place, Chloé Copin, et al.
European Journal of Medicinal Chemistry|May 21, 2018
Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitorsBruno Oyallon, Marie Brachet-Botineau, Cédric Logé, et al.
European Journal of Medicinal Chemistry|July 6, 2015
Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitorsRajâa Boulahjar, Aziz Ouach, Stéphane Bourg, et al.
European Journal of Medicinal Chemistry|May 14, 2020
Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potencyNada Ibrahim, Pascal Bonnet, Jean-Daniel Brion, et al.
European Journal of Medicinal Chemistry|February 1, 2026
New fluoxetine analogues as anti-enterovirus agents targeting 2C proteinSafeh Khemiri, Marine O Faucher, Stephane Bourg, et al.
Molecules (Basel, Switzerland)|September 10, 2021
Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3,2-<i>d</i>]Pyrimidine Series as Novel PI3K/mTOR InhibitorsFrédéric Buron, Nuno Rodrigues, Thibault Saurat, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Enzyme Inhibition and Medicinal Chemistry|June 7, 2022
Design and biological evaluation of substituted 5,7-dihydro-6<i>H</i>-indolo[2,3-<i>c</i>]quinolin-6-one as novel selective Haspin inhibitorsSreenivas Avula, Xudan Peng, Xingfen Lang, et al.
Virologie (Montrouge, France)|November 3, 2025
[Prozac 2.0 : from antidepressant to antiviral]Marine O Faucher, Safeh Khemiri, Carole Yaacoub, et al.
Journal of Medicinal Chemistry|January 23, 2015
Structural investigation of B-Raf paradox breaker and inducer inhibitorsRohit Arora, Michela Di Michele, Elisabeth Stes, et al.
Journal of Medicinal Chemistry|July 8, 2016
Correction to Structural Investigation of B-Raf Paradox Breaker and Inducer InhibitorsRohit Arora, Michela Di Michele, Elisabeth Stes, et al.
European Journal of Medicinal Chemistry|May 23, 2026
Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationshipsStéphane Bourg, Matthieu Place, Chloé Copin, et al.
European Journal of Medicinal Chemistry|May 21, 2018
Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitorsBruno Oyallon, Marie Brachet-Botineau, Cédric Logé, et al.
European Journal of Medicinal Chemistry|July 6, 2015
Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitorsRajâa Boulahjar, Aziz Ouach, Stéphane Bourg, et al.
European Journal of Medicinal Chemistry|May 14, 2020
Identification of a new series of flavopiridol-like structures as kinase inhibitors with high cytotoxic potencyNada Ibrahim, Pascal Bonnet, Jean-Daniel Brion, et al.
European Journal of Medicinal Chemistry|February 1, 2026
New fluoxetine analogues as anti-enterovirus agents targeting 2C proteinSafeh Khemiri, Marine O Faucher, Stephane Bourg, et al.
Molecules (Basel, Switzerland)|September 10, 2021
Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3,2-<i>d</i>]Pyrimidine Series as Novel PI3K/mTOR InhibitorsFrédéric Buron, Nuno Rodrigues, Thibault Saurat, et al.
Pageof 8